Drugs for Social Phobia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 128)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Vortioxetine |
Approved, Investigational |
Phase 4 |
|
508233-74-7 |
9966051 |
Synonyms:
1-(2-(2,4-Dimethylphenylsulfanyl)phenyl)piperazine
1-{2-[(2,4-dimethylphenyl)sulphanyl]phenyl}piperazine
Brintellix
Brintellix®|Lu AA21004|Trintellix®
LU AA21004
LUAA21004
LU-AA21004
|
TRINTELLIX
VORTIOXETINA
VORTIOXETINE
VORTIOXÉTINE
Vortioxetine hydrobromide
VORTIOXETINUM
|
|
2 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
3 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
4 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
5 |
|
Paroxetine |
Approved, Investigational |
Phase 4 |
|
61869-08-7 |
43815 |
Synonyms:
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(−)-(3S,4R)-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
Acetate, paroxetine
Anhydrous, paroxetine hydrochloride
Aropax
BRL-29060
Hemihydrate paroxetine hydrochloride
Hemihydrate, paroxetine hydrochloride
Hydrochloride anhydrous, paroxetine
Hydrochloride hemihydrate, paroxetine
Hydrochloride, hemihydrate paroxetine
Hydrochloride, paroxetine
Maleate, paroxetine
Paroxetina
Paroxetina [INN-Spanish]
PAROXETINE
Paroxetine acetate
|
Paroxetine Hcl
Paroxetine hydrochloride
paroxetine hydrochloride (anhydrous or hemihydrate)|Paxil®|Seroxat®
Paroxetine hydrochloride anhydrous
Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride, hemihydrate
Paroxetine maleate
Paroxetine, cis-(-)-isomer
Paroxetine, cis-(+)-isomer
Paroxetine, trans-(+)-isomer
Paroxetinum
Paroxetinum [INN-Latin]
Paxil
PAXIL [AS HYDROCHLORIDE]
Paxil CR
PEXEVA
Seroxat
Seroxat CR
|
|
6 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
Abilify
ABILIFY MAINTENA
ABILIFY MAINTENA KIT
ABILIFY MYCITE KIT
Abilify®|Aripiprex®|Aristada® (aripiprazole lauroxil)|OPC 14597|OPC-14597
Abilitat
Aripiprazol
|
ARIPIPRAZOLE
Aripiprazolum
ARIPIPREX
OPC 14597
OPC 31
OPC-14597
OPC-31
|
|
7 |
|
Venlafaxine |
Approved |
Phase 4 |
|
99300-78-4, 93413-69-5 |
5656 |
Synonyms:
1-(2-(dimethylamino)-1-(4-Methoxyphenyl)ethyl)cyclohexanol HCL
1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXAN-1-OL
ALVENTA XL
AMPHERO XL
BONILUX XL
Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
DEPEFEX XL
Dobupal
Efectin
Efexor
EFEXOR XL
Effexor
EFFEXOR XR
Effexor®|WY-45030
Elafax
FORAVEN XL
Hydrochloride, venlafaxine
MENTAVEN XL
POLITID XL
RANFAXINE XL
RODOMEL XL
Sila venlafaxine
Sila-venlafaxine
SUNVENIZ XL
TARDCAPS XL
TIFAXIN XL
|
TONPULAR XL
Trevilor
TRIXAT XL
Vandral
VAXALIN XL
VENAXX XL
VENLABLUE XL
VENLADEX XL
Venlafaxin
Venlafaxina
Venlafaxina [INN-Spanish]
VENLAFAXINE
Venlafaxine [INN:Ban]
VENLAFAXINE HCL
Venlafaxine hydrochloride
Venlafaxinum
Venlafaxinum [INN-Latin]
Venlafexine
VENLALIC XL
VENLANEO XL
VENSIR XL
VEXARIN XL
VIEPAX
VIEPAX XL
WINFEX XL
WY-45030
|
|
8 |
|
Atomoxetine |
Approved |
Phase 4 |
|
82248-59-7, 83015-26-3 |
54841 |
Synonyms:
(-)-Tomoxetine
Atomoxetina
Atomoxetine
Atomoxetine HCL
Atomoxetine hydrochloride
HCL, Atomoxetine
Hydrochloride, atomoxetine
LY-139603
LY-139603|Strattera®
N-Methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride
Strattera
|
Tomoxetina
Tomoxetina [Spanish]
Tomoxetine
Tomoxetine [INN]
TOMOXETINE HCL
Tomoxetine hydrochloride, (-)-isomer
Tomoxetine hydrochloride, (+-)-isomer
Tomoxetine hydrochloride, (+)-isomer - T351671
Tomoxetinum
Tomoxetinum [Latin]
|
|
9 |
|
Nefazodone |
Approved, Withdrawn |
Phase 4 |
|
82752-99-6, 83366-66-9 |
4449 |
Synonyms:
1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one
1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-δ2-1,2,4-triazolin-5-one
Apo-nefazodone
Apotex brand OF nefazodone hydrochloride
BMY-13754
BMY-13754|MJ-13754-1|Nefadar®
Bristol-myers brand OF nefazodone hydrochloride
Bristol-myers squibb brand OF nefazodone hydrochloride
Dutonin
Europharma brand OF nefazodone hydrochloride
Hormosan brand OF nefazodone hydrochloride
Lin-nefazodone
Linson pharma brand OF nefazodone hydrochloride
|
Menarini brand OF nefazodone hydrochloride
Menfazona
MJ-13754-1
Nefadar
Nefazodona
Nefazodona [Spanish]
NEFAZODONE
NEFAZODONE HCL
Nefazodone hydrochloride
Nefazodonum
Nefazodonum [Latin]
Rulivan
Serzone
|
|
10 |
|
Acamprosate |
Approved, Investigational |
Phase 4 |
|
77337-73-6, 77337-76-9 |
71158 |
Synonyms:
3-(Acetylamino)propanesulphonic acid
3-Acetamido-1-propanesulfonate
3-Acetamido-1-propanesulfonic acid
3-Acetamido-1-propanesulphonate
3-Acetamido-1-propanesulphonic acid
Acamprosate
Acamprosate calcium
Acamprosato
Acamprosatum
Acamprosic acid
Acamprostate
Acetyl homotaurinate, calcium
Acetylhomotaurinate, calcium
Acetylhomotaurine, calcium
Acetylhomotaurine, sodium
AOTA
Aotal
Calcium acetyl homotaurinate
Calcium acetylhomotaurinate
|
Calcium acetylhomotaurine
Campral
Campral ec
N Acetylhomotaurine
N Acetylhomotaurine, monolithium salt
N Acetylhomotaurine, monopotassium salt
N Acetylhomotaurine, monosodium salt
N-acetyl homotaurine
N-Acetylhomotaurine
N-Acetylhomotaurine, calcium (2:1) salt
N-Acetylhomotaurine, magnesium (2:1) salt
N-Acetylhomotaurine, monolithium salt
N-Acetylhomotaurine, monopotassium salt
N-Acetylhomotaurine, monosodium salt
N-Acetylhomotaurine, zinc (2:1) salt
Regtect
Sodium acetylhomotaurine
Zulex
|
|
11 |
|
Clonazepam |
Approved, Illicit |
Phase 4 |
|
1622-61-3 |
2802 |
Synonyms:
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Antelepsin
Chlonazepam
CLONAZEPAM
CLONAZEPAM CIV
Clonazepam fine granules
Clonazepam tablets
|
Clonazepamum
Klonopin
KLONOPIN RAPIDLY DISINTEGRATING
Klonopin®|Ro-5-4023|Ro-54023
NSC-179913
Rivotril
RO-54023
RO-5-4023
RO-5423
|
|
12 |
|
Tiagabine |
Approved, Investigational |
Phase 4 |
|
115103-54-3 |
60648 |
Synonyms:
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotate
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
(R)-(-)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate
(R)-(-)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
(R)-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride
(R)-Tiagabine
A-70569-1
ABBOTT-70569
ABBOTT-70569 FREE BASE
ABBOTT-70569|ABT-569|Gabitril®|tiagabine hydrochloride
ABBOTT-70569-1
ABBOTT-705691 FREE BASE
|
ABT-569
ABT-569 FREE BASE
Gabitril
N-(4,4-Di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
NNC-05-0328
NNC-050328 FREE BASE
NO-05-0328
NO-050328 FREE BASE
Tiagabina
TIAGABINE
Tiagabine hydrochloride
Tiagabine, (S)-isomer
Tiagabinum
|
|
13 |
|
Cariprazine |
Approved, Investigational |
Phase 4 |
|
839712-12-8 |
11154555 |
Synonyms:
CARIPRAZINE
GED-129
MP-214
REAGILA
Reagila®|RGH 188|RGH-188|Vraylar®
|
RGH 188
RGH-188
TRANS-N-{4-[2-[4-(2,3-DICHLOROPHENYL)PIPERAZINE-1-YL]ETHYL]CYCLOHEXYL}-N’,N’-DIMETHYLUREA HYDROCHLORIDE
VRAYLAR
|
|
14 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
15 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Î’-propranolol
|
|
16 |
|
Sertraline |
Approved |
Phase 4 |
|
79617-96-2 |
68617 |
Synonyms:
(+)-Sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
Altruline
Apo sertraline
Apo-sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
Boehringer ingelheim brand OF sertraline hydrochloride
cis-(+)-Sertraline
CP 51974
CP-519741
CP-51974-1
CP-51974-1|CP-519741|Lustral®|Zoloft®
Esteve brand OF sertraline hydrochloride
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
Hydrochloride, sertraline
Lacer brand OF sertraline hydrochloride
Lustral
|
Novo sertraline
Novopharm brand OF sertraline hydrochloride
Novo-sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Ratio sertraline
Ratiopharm brand OF sertraline hydrochloride
Ratio-sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
SERTRALINE
Sertraline hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
Sultamicillin Tosylate
Zoloft
|
|
17 |
|
Topiramate |
Approved |
Phase 4 |
|
97240-79-4 |
5284627 |
Synonyms:
[(1R,2S,6S,9R)-4,4,11,11-TETRAMETHYL-3,5,7,10,12-PENTAOXATRICYCLO[7.3.0.0^{2,6}]DODECAN-6-YL]METHYL SULFAMATE
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
|
Epitomax
epitomax|Eprontia® (liquid formulation)|MCN-4853|RWJ-17021|Topamax®
MCN-4853
QUDEXY XR
RWJ-17021
RWJ-17021-000
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
Topamax
Topamax sprinkle
TOPIRAMATE
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
TPM
Trokendi XR
USL255
USL-255
|
|
18 |
|
Dexetimide |
Withdrawn |
Phase 4 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
19 |
|
Serotonin 5-HT3 Receptor Antagonists |
|
Phase 4 |
|
|
|
20 |
|
Quetiapine Fumarate |
|
Phase 4 |
|
111974-72-2 |
|
Synonyms:
ICI-204636
QUETIAPINE FUMARATE
SEROQUEL
|
SEROQUEL XR
ZD-5077
ZM-204636
|
|
21 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
22 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
23 |
|
Serotonin 5-HT1 Receptor Agonists |
|
Phase 4 |
|
|
|
24 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
25 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
26 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
27 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
28 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
29 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
30 |
|
Desvenlafaxine Succinate |
|
Phase 4 |
|
386750-22-7 |
|
Synonyms:
DESVENLAFAXINE SUCCINATE
DESVENLAFAXINE SUCCINATE ANHYDROUS
DESVENLAFAXINE SUCCINATE HYDRATE
DESVENLAFAXINE SUCCINATE MONOHYDRATE
|
|
|
31 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
32 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
33 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
34 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
35 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
36 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
37 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
38 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
39 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
40 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
41 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
42 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
43 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
44 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
45 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
46 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
47 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
48 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
49 |
|
Memantine |
Approved, Investigational |
Phase 3 |
|
41100-52-1, 19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
1,3-DIMETHYLAMINOADAMANTANE
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
AKATINOL
Axura
Axura®|Ebixa®|Namenda®
D-145
DMAA
DRG-0267
Ebixa
Exiba
FP-01
Lundbeck brand OF memantine hydrochloride
|
MARIXINO
Memantin
Memantina
Memantina [INN-Spanish]
MEMANTINE
Memantine [INN]
MEMANTINE HCL
Memantine hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
Namenda
NAMENDA XR
NEMDATINE
NSC-102290
SUN-Y7017
VALIOS
|
|
50 |
|
Riluzole |
Approved, Investigational |
Phase 2, Phase 3 |
|
1744-22-5 |
5070 |
Synonyms:
2 Amino 6 trifluoromethoxybenzothiazole
2-Amino-6-trifluoromethoxybenzothiazole
Aventis behring brand OF riluzole
Aventis brand OF riluzole
BHV-0223
Impax brand OF riluzole
Rhone poulenc rorer brand OF riluzole
Rhone-poulenc rorer brand OF riluzole
Rilutek
|
Rilutek®|RP-54274|Tiglutik® (thickened oral suspension)
RILUZOL
RILUZOLE
Riluzole aventis brand
Riluzole impax brand
RILUZOLUM
RP-54274
TEGLUTIK
TIGLUTIK KIT
|
|
Interventional clinical trials:
(show top 50)
(show all 269)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder |
Unknown status |
NCT02294305 |
Phase 4 |
Vortioxetine;Placebo |
2 |
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity |
Unknown status |
NCT03785223 |
Phase 4 |
Methylphenidate Hydrochloride Controlled-Release Capsules;Placebo Capsule |
3 |
D-Cycloserine Enhancement of Exposure in Social Phobia |
Completed |
NCT00633984 |
Phase 4 |
D-Cycloserine;Placebo |
4 |
The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Effects on Cue Reactivity in Response to Virtual Reality Public Speaking Environment |
Completed |
NCT00407199 |
Phase 4 |
quetiapine |
5 |
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety |
Completed |
NCT00177008 |
Phase 4 |
Aripiprazole |
6 |
Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder |
Completed |
NCT00190879 |
Phase 4 |
Atomoxetine hydrochloride;placebo |
7 |
Nefazodone in the Treatment of Social Phobia: Functional Brain Imaging and Neuroendocrine Correlates |
Completed |
NCT00231348 |
Phase 4 |
Nefazodone |
8 |
Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes |
Completed |
NCT00347269 |
Phase 4 |
Psychotropic medication optimization |
9 |
The Use of Acamprosate in Individuals With Alcohol Dependence and Comorbid Anxiety or Depression |
Completed |
NCT00330174 |
Phase 4 |
Acamprosate |
10 |
Improving Outcomes in Pharmacotherapy of Social Phobia |
Completed |
NCT00282828 |
Phase 4 |
Sertraline;Venlafaxine;Placebo;Clonazepam |
11 |
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism |
Completed |
NCT00246441 |
Phase 4 |
Paroxetine;Placebo |
12 |
A 12-Week Open-Label Study Followed By A 24-Week Double-Blind Discontinuation Exploratory Study To Evaluate The Effects Of Gabitrilâ„¢ (Tiagabine Hydrochloride) In Patients With Social Anxiety Disorder (SAD) |
Completed |
NCT00208741 |
Phase 4 |
Gabitril |
13 |
Efficacy and Safety of Escitalopram in Patients With Social Anxiety Disorder; Open-label, One Arm Postmarketing Study in Russia |
Completed |
NCT00902226 |
Phase 4 |
Escitalopram |
14 |
Comparative Effectiveness of Mindfulness-Based Stress Reduction and Pharmacotherapy for Anxiety |
Completed |
NCT03522844 |
Phase 4 |
Escitalopram |
15 |
A Double-Blind, Placebo-Controlled, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults |
Completed |
NCT01224067 |
Phase 4 |
Quetiapine |
16 |
A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Pristiq® (Desvenlafaxine) Extended-Release Tablets in Generalized Social Anxiety Disorder |
Completed |
NCT01316302 |
Phase 4 |
Pristiq;Placebo |
17 |
A Randomised, Triple Blind, Placebo-controlled Trial Comparing the Effects of Cognitive Therapy, Paroxetine and Both Cognitive Therapy and Paroxetine in the Treatment of Patients With Primary Social Phobia |
Completed |
NCT00184106 |
Phase 4 |
Seroxat, Cognitive therapy, Seroxat+ cognitive therapy |
18 |
Vraylar® (Cariprazine) in the Treatment of Social Anxiety Disorder: A Double-Blind Study |
Not yet recruiting |
NCT05384483 |
Phase 4 |
Cariprazine;Placebo |
19 |
A Controlled Study of the Efficacy of Botulinum Toxin A (Botox) for the Treatment of Social Anxiety Disorder (SAD) |
Terminated |
NCT03078270 |
Phase 4 |
botulinum toxin A |
20 |
Brief Intervention to Reduce Fear of Public Speaking |
Terminated |
NCT02790736 |
Phase 4 |
propranolol;Placebo |
21 |
Sertraline in the Treatment of Generalized Social Phobia With Comorbidity |
Terminated |
NCT00182533 |
Phase 4 |
Sertraline;Placebo |
22 |
Topiramate Augmentation to a Selective Serotonin Re-uptake Inhibitor (SSRI) in Treatment-Resistant Generalized Social Phobia: A Double-Blind Placebo -Controlled Trial. |
Terminated |
NCT00182455 |
Phase 4 |
Topiramate;Placebo |
23 |
Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice (SophoPrax) |
Unknown status |
NCT01388231 |
Phase 2, Phase 3 |
|
24 |
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of PH94B Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder |
Completed |
NCT04754802 |
Phase 3 |
PH94B Nasal Spray;Placebo Nasal Spray |
25 |
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD) |
Completed |
NCT02622958 |
Phase 3 |
PH94B |
26 |
A Single-center, Randomized, Double-blind, Phase III Comparison of the Efficacy and Safety of Quetiapine Fumarate (Oral Extended Release Tablets) to Placebo in Social Phobia Patients and Changes in Their Vasodilatory Response to Methyl-Nicotinate |
Completed |
NCT00773162 |
Phase 3 |
Seroquel;Sugar Pill |
27 |
D-cycloserine Enhancement of Exposure in Social Phobia |
Completed |
NCT00515879 |
Phase 3 |
D-cycloserine;Placebo |
28 |
A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder (GAD) or Social Anxiety Disorder (SAD), Who Are Only Partial Responders to Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRI's) or Selective Serotonin Reuptake Inhibitors (SSRI's). |
Completed |
NCT00411398 |
Phase 3 |
Namenda/Memantine |
29 |
Double-Blind, Placebo-Controlled, Single-Dose Crossover Study Examining the Effects of Sublingual Riluzole (BHV-0223) on Public Speaking in Social Anxiety Disorder |
Completed |
NCT03017508 |
Phase 2, Phase 3 |
BHV-0223;Placebo |
30 |
Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome |
Completed |
NCT00114127 |
Phase 3 |
Duloxetine;Placebo |
31 |
Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia |
Completed |
NCT00958880 |
Phase 3 |
Yohimbine Hydrochloride;Sugar Pill |
32 |
Child/Adolescent Anxiety Multimodal Treatment Study |
Completed |
NCT00052078 |
Phase 3 |
Sertraline (SRT);Placebo |
33 |
Treatment of Childhood Social Phobia |
Completed |
NCT00043537 |
Phase 3 |
Fluoxetine;Pill Placebo |
34 |
A Systems Level Intervention for Unemployed Persons With Social Anxiety |
Completed |
NCT01654510 |
Phase 2, Phase 3 |
|
35 |
A Comparison Between Internet-based Self-help Therapy and Group Therapy for Social Phobia - A Clinical Equivalence Trial Using Cognitive Behavioural Therapy (CBT) |
Completed |
NCT00564967 |
Phase 3 |
|
36 |
Placebo-Controlled Trial of Hypericum Perforatum in the Treatment of Generalized Social Anxiety Disorder (GSAD) |
Completed |
NCT00118833 |
Phase 2, Phase 3 |
Hypericum perforatum (St. John's wort) |
37 |
Research Unit on Pediatric Psychopharmacology Anxiety Treatment Study |
Completed |
NCT00000389 |
Phase 3 |
Fluvoxamine |
38 |
CBT Augmentation of Paroxetine for Social Anxiety |
Completed |
NCT00074802 |
Phase 3 |
Paroxetine |
39 |
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Quetiapine in Social Anxiety Disorder |
Completed |
NCT00215254 |
Phase 2, Phase 3 |
quetiapine |
40 |
Residential Cognitive Therapy Versus Residential Interpersonal Therapy for Social Phobia: A Randomized Controlled Trial |
Completed |
NCT00326430 |
Phase 2, Phase 3 |
|
41 |
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Double-blind, Placebo-controlled Study- <Phase III Study> |
Completed |
NCT00318669 |
Phase 3 |
Paroxetine hydrochloride hydrate |
42 |
A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine ER In Children and Adolescent Outpatients With Social Anxiety Disorder |
Completed |
NCT00238719 |
Phase 3 |
Venlafaxine ER |
43 |
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Open-Label, Uncontrolled, Long-term Study- <Phase III Study> |
Completed |
NCT00264654 |
Phase 3 |
BRL29060A;paroxetine hydrochloride hydrate |
44 |
Double Blind Placebo Controlled Parallel Group Comparison of Atomoxetine (Strattera) for Generalized Social Anxiety Disorder (GSAD) |
Completed |
NCT00260533 |
Phase 2, Phase 3 |
atomoxetine;placebo |
45 |
A Randomized, Controlled Study of a Stepped-care Model for the Treatment of Social Phobia and Panic Disorder in Adults |
Completed |
NCT00619138 |
Phase 3 |
|
46 |
Utilizing Health Information Technology to Improve Health Care Quality: Implementation of a Computerized Cognitive Behavioral Therapy Protocol for Childhood Anxiety |
Completed |
NCT01416805 |
Phase 3 |
|
47 |
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders |
Completed |
NCT01178385 |
Phase 2, Phase 3 |
|
48 |
Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder: Comparison of Therapist-Led and Therapist Assisted Approaches |
Recruiting |
NCT04922502 |
Phase 2, Phase 3 |
|
49 |
A US, Phase 3 Multicenter, Randomized, Double-blind, Placebo Controlled Trial of PH94B Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder (PaliSADe-2) |
Recruiting |
NCT05011396 |
Phase 3 |
PH94B Nasal Spray;Placebo Nasal Spray |
50 |
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study |
Not yet recruiting |
NCT03549819 |
Phase 3 |
Cannabidiol (CBD) Oil Capsules;Sunflower Lecithin Oil in Capsule |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
gabapentin
gabapentin enacarbil
|
Paroxetine
Paroxetine Hydrochloride
|
Cochrane evidence based reviews: phobia, social
|